AXSM — Axsome Therapeutics, Inc.
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 1579428 ·
Last close
$195.09
Market Cap
$10.22B
52W High
$260.19
52W Low
$115.72
ADV30
589,110
Next earnings
2026-11-02
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 218,375,000 | 204,811,000 | -51,142,000 | -51,314,000 | 761,447,000 | 319,850,000 | 678,143,000 |
| Mar 2026 | 191,203,000 | 176,478,000 | -62,767,000 | -64,542,000 | 713,607,000 | 305,106,000 | 659,020,000 |
| Dec 2025 | 195,999,000 | 183,670,000 | -36,025,000 | -28,559,000 | 689,805,000 | 322,933,000 | 601,510,000 |
| Sep 2025 | 170,992,000 | 159,080,000 | -32,924,000 | -47,229,000 | 669,250,000 | 325,272,000 | 595,523,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-70,730,000
Investing CF
$-263,000
Financing CF
$75,189,000
CapEx
$-263,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-3.73
As of
2026-08-16
Balance + Analyst (yfinance extras)
Retained Earnings
$-1,370,503,000
Inventory
$31,515,000
Receivables
$251,062,000
ST Investments
—
EBIT TTM
$-183,522,000
Pretax Income TTM
$-188,833,000
Interest Exp TTM
$5,311,000
Analysts
21
Yahoo Snapshot (yfinance, live)
Total Revenue
$776,569,024
EBITDA
$-172,919,008
Free Cash Flow
$-4,581,750
Enterprise Value
$11,467,908,096
Total Cash
$319,849,984
Total Debt
$224,692,992
Shares Out
52,380,818
Trailing EPS
$-3.75
Book Value
$1.59
ROE
-245.1%
ROA
-16.3%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 638,496,000 | -169,235,000 | -183,174,000 | 689,805,000 | 601,510,000 | 88,295,000 | -93,405,000 |
| Dec 2024 | 385,693,000 | -252,438,000 | -287,216,000 | 568,498,000 | 511,483,000 | 57,015,000 | -128,410,000 |
| Dec 2023 | 270,600,000 | -182,907,000 | -239,238,000 | 588,236,000 | 397,259,000 | 190,977,000 | -145,080,000 |
| Dec 2022 | 50,037,000 | -176,501,000 | -187,134,000 | 331,476,000 | 221,920,000 | 109,556,000 | -116,511,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$5.03
Max Pain — expiry 2027-01-15
max pain strike: $170.00 · spot: $196.21 · call oi: 7,771 · put oi: 8,096
Expected Move to 2027-01-15:
±$35.50
(18.09%) —
implied range
$160.71 –
$231.71
· ATM straddle on $195.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| RDY | DR REDDYS LABORATORIES LTD | $10.20B | $12.25 | — |
| ELAN | Elanco Animal Health Inc | $11.14B | $22.31 | — |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | $9.31B | $65.92 | — |
| PTGX | Protagonist Therapeutics, Inc | $9.18B | $141.86 | — |
| CYTK | CYTOKINETICS INC | $8.99B | $64.66 | — |
News headlines (Yahoo Finance, 1h cache)
Axsome Therapeutics Announces Results of the Shared Goals Survey of Caregivers of Patients with Alzheimer’s Disease Agitation Presented at Psych Congress 2026 in Connection with World Alzheimer’s Day
2026-09-21 11:00 · Yahoo
Axsome Sees AUVELITY Prescriptions Accelerate as Alzheimer’s Launch Gains Traction
2026-09-19 18:02 · Yahoo
Axsome Therapeutics (AXSM) Stock Looks Undervalued As Its 5 Year 7x Run Continues
2026-09-19 13:11 · Yahoo
Is Axsome Therapeutics’ (AXSM) New CNS Data Enough To Reinforce Its Neuropsychiatric Portfolio Story?
2026-09-19 11:14 · Yahoo
Axsome Therapeutics Highlights Auvelity Growth, Pipeline Progress at H.C. Wainwright Conference
2026-09-19 08:02 · Yahoo
Axsome Therapeutics (AXSM) Reported New Clinical Data In Depression And Alzheimer’s Agitation
2026-09-19 04:18 · Yahoo
Analysts Think Axsome Therapeutics Stock Could Soar 35% Over the Next 12 Months. Is the Stock a No-Brainer Buy?
2026-09-18 22:22 · Yahoo
Axsome Therapeutics vs. Moderna: Which Healthcare Stock Is a Better Buy in 2026?
2026-09-18 19:25 · Yahoo
Axsome Therapeutics vs. Revolution Medicines: Which Healthcare Stock Is a Better Buy in 2026?
2026-09-18 13:00 · Yahoo
Is Axsome Therapeutics a Buy on the Dip?
2026-09-18 07:05 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.